Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for C4 Therapeutics Inc have a median target of 14.00, with a high estimate of 39.00 and a low estimate of 8.00. The median estimate represents a 249.13% increase from the last price of 4.01.
High | 872.6% | 39.00 |
Med | 249.1% | 14.00 |
Low | 99.5% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | +4.03% |
Average growth rate | +7.89% |
More ▼
Revenue history & estimates in USD
Average growth rate | +61.42% |
Average growth rate | -9.14% |
More ▼